Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / RVNC - Revance Therapeutics Inc. (RVNC) CEO Mark Foley on Q1 2021 Results - Earnings Call Transcript

RVNC - Revance Therapeutics Inc. (RVNC) CEO Mark Foley on Q1 2021 Results - Earnings Call Transcript

Revance Therapeutics Inc.
Revance Therapeutics, Inc. (RVNC) Q1 2021 Results Conference Call May 10, 2021 04:30 PM ET Company Participants Jessica Serra - Head, IR and ESG Mark Foley - President and CEO Toby Schilke - CFO Dr. Abhay Joshi - COO and President, R&D and Product Operations Dustin Sjuts - Chief Commercial Officer, Aesthetics and Therapeutics Aubrey Rankin - President, Innovation and Technology Conference Call Participants Ken Cacciatore - Cowen & Company Seamus Fernandez - Guggenheim Terence Flynn - Goldman Sachs Annabel Samimy - Stifel Balaji Prasad - Barclays Tim Lugo - William Blair David Amsellem - Piper Sandler Chico Hughes - Wells Fargo Securities Vamil Divan - Mizuho Securities Serge Belanger - Needham & Company Chris Bialas - H.C. Wainwright Presentation Operator Welcome to the Revance Therapeutics First Quarter 2021 Financial Results and Corporate Update Conference Call. [Operator Instructions] As a reminder, this call is being recorded today, May 10, 2021.

For further details see:

Revance Therapeutics, Inc. (RVNC) CEO Mark Foley on Q1 2021 Results - Earnings Call Transcript
Stock Information
Company Name: Revance Therapeutics Inc.
Stock Symbol: RVNC
Market: NASDAQ
Website: revance.com
Menu
RVNC RVNC Quote RVNC Short RVNC News RVNC Articles RVNC Message Board
Get RVNC Alerts

News, Short Squeeze, Breakout and More Instantly...